thiazoles has been researched along with Myeloproliferative Disorders in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Bledsoe, S; Borthakur, GM; Bose, P; Bueso-Ramos, CE; Carter, BZ; Cortes, J; Daver, NG; DiNardo, CD; Estrov, ZE; Garcia-Manero, G; Jabbour, E; Jain, N; Kadia, TM; Konopleva, MY; Mak, PY; Masarova, L; Ohanian, M; Pemmaraju, N; Pierce, S; Popat, U; Qiao, W; Verstovsek, S; Wang, X; Zhou, L | 1 |
Albizua, E; Arenas, A; Ayala, R; Barrio, S; Burgaleta, C; Gallardo, M; Gilsanz, F; Jiménez-Ubieto, A; Martinez-Lopez, J; Rapado, I; Rueda, D | 1 |
Dagger, SA; Duyvestyn, JM; Langdon, WY; Morse, HC; Orandle, M; Taylor, SJ; Thien, CB | 1 |
Cortes, JE; Huh, Y; Kanagal-Shamanna, R; Kantarjian, HM; Lin, P; Loghavi, S; Luthra, R; Medeiros, LJ; Mehrotra, M; Patel, KP; Pemmaraju, N; Verstovsek, S | 1 |
Amrein, PC | 1 |
Fukushima, N; Ichinohe, T; Kimura, S | 1 |
2 review(s) available for thiazoles and Myeloproliferative Disorders
Article | Year |
---|---|
The potential for dasatinib in treating chronic lymphocytic leukemia, acute myeloid leukemia, and myeloproliferative neoplasms.
Topics: Dasatinib; Hematologic Neoplasms; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Myeloproliferative Disorders; Protein Kinase Inhibitors; Pyrimidines; Thiazoles | 2011 |
[Myeloproliferative neoplasms (including chronic myeloid leukemia)].
Topics: Benzamides; Dasatinib; Humans; Imatinib Mesylate; Janus Kinase 2; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Targeted Therapy; mRNA Cleavage and Polyadenylation Factors; Mutation; Myeloproliferative Disorders; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Randomized Controlled Trials as Topic; Receptor, Platelet-Derived Growth Factor alpha; Thiazoles | 2012 |
1 trial(s) available for thiazoles and Myeloproliferative Disorders
Article | Year |
---|---|
Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelofibrosis.
Topics: Apoptosis; Humans; Myeloproliferative Disorders; Primary Myelofibrosis; Thiazoles | 2021 |
3 other study(ies) available for thiazoles and Myeloproliferative Disorders
Article | Year |
---|---|
Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cell Proliferation; Cells, Cultured; Chronic Disease; Dasatinib; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Female; Humans; Janus Kinase 2; Janus Kinases; Male; Middle Aged; Myeloproliferative Disorders; Niacinamide; Nitriles; Phenylurea Compounds; Phosphorylcholine; Polycythemia Vera; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Pyrrolidinones; Signal Transduction; Sorafenib; STAT5 Transcription Factor; Thiazoles; Thrombocythemia, Essential; Tumor Cells, Cultured | 2013 |
Dasatinib targets B-lineage cells but does not provide an effective therapy for myeloproliferative disease in c-Cbl RING finger mutant mice.
Topics: Animals; B-Lymphocytes; Bone Marrow Cells; Cell Lineage; Dasatinib; Dose-Response Relationship, Drug; Germinal Center; Hematopoietic Stem Cells; Humans; Lymphocyte Count; Male; Mice, Inbred C57BL; Mice, Mutant Strains; Myeloproliferative Disorders; Neutrophils; Phosphorylation; Phosphotyrosine; Precursor Cells, B-Lymphoid; Proto-Oncogene Proteins c-cbl; Pyrimidines; RING Finger Domains; src-Family Kinases; Thiazoles | 2014 |
Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1.
Topics: Aged; Antineoplastic Agents; Calreticulin; Dasatinib; Fusion Proteins, bcr-abl; Humans; In Situ Hybridization, Fluorescence; Male; Myeloproliferative Disorders; Protein Kinase Inhibitors; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles | 2015 |